Rapid detection of low-abundance K-ras mutation in stools of colorectal cancer patients using chip-based temperature gradient capillary electrophoresis

Laboratory Investigation

Volumn 91, Issue 5, 2011, Pages 788-798

  Zhang, Huidan ^a   Wang, Xiaonan ^a   Ma, Qian ^a   Zhou, Zhe ^a   Fang, Jin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

colorectal cancer; K ras; microfluidic chip; mutation detection; stool; temperature gradient capillary lectrophoresis (TGCE)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; MUTANT PROTEIN;

ARTICLE; CANCER SCREENING; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DNA DETERMINATION; FECES ANALYSIS; GENE MUTATION; GENOTYPE; HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BASE SEQUENCE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA PRIMERS; ELECTROPHORESIS, CAPILLARY; FECES; GENES, RAS; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 79955549712     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.200     Document Type: Article

References (45)

1. Jiang Y, Kimchi ET, Staveley-OCarroll KF, et al. Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer. Cancer 2009;115:3609-3617.
2. Eng C. The evolving role of monoclonal antibodies in colorectal cancer: early presumptions and impact on clinical trial development. Oncologist 2010;15:73-84.
3. Ma WW, Adjei AA. Novel agents on the horizon for cancer therapy. CA Cancer J Clin 2009;59:111-137.
4. Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 2008;359:1757-1765.
5. Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 2008;26:1626-1634.
6. Waldner MJ, Neurath MF. The molecular therapy of colorectal cancer. Mol Aspects Med 2010;31:171-178.
7. Allegra CJ, Jessup JM, Somerfield MR, et al. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 2009;27:2091-2096.
8. Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005;128:192-206. (Pubitemid 40039970)
9. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi- Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-160. (Pubitemid 351830299)
10. Chung DC. Stool DNA testing and colon cancer prevention: another step forward. Ann Intern Med 2008;149:509-510.
11. Hasegawa Y, Takeda S, Ichii S, et al. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal colorectal tumors by mutant-allele-specific amplification (MASA). Oncogene 1995;10: 1441-1445.
12. Zou H, Taylor WR, Harrington JJ, et al. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology 2009;136:459-470.
13. Nishikawa T, Maemura K, Hirata I, et al. A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis. Clin Chim Acta 2002;318:107-112. (Pubitemid 34195593)
14. Notarnicola M, Cavallini A, Cardone R, et al. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer. Dig Liver Dis 2000;32:131-136. (Pubitemid 30236484)
15. Ho-Pun-Cheung A, Choblet S, Choblet S, et al. Detection of single nucleotide polymorphisms by minisequencing on a polypyrrole DNA chip designed for medical diagnosis. Lab invest 2006;86:304-313. (Pubitemid 43276962)
16. Murphy KM, Berg KD. Mutation and single nucleotide polymorphism detection using temperature gradient capillary electrophoresis. Expert Rev Mol Diagn 2003;3:811-818. (Pubitemid 37428967)
17. Gelfi C, Righetti PG, Cremonesi L, et al. Detection of point mutations by capillary electrophoresis in liquid polymers in temporal thermal gradients. Electrophoresis 1994;15:1506-1511.
18. Sheffield VC, Cox DR, Lerman LS, et al. Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci USA 1989;86:232-236. (Pubitemid 19036361)
19. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67. (Pubitemid 24144355)
20. Bian Y, Matsubayashi H, Li CP, et al. Detecting low-abundance p16 and p53 mutations in pancreatic juice using a novel assay: heteroduplex analysis of limiting dilution PCRs. Cancer Biol Ther 2006;5: 1392-1399. (Pubitemid 44773687)
21. Kleparńk K, Bocek P. DNA diagnostics by capillary electrophoresis. Chem Rev 2007;107:5279-5317.
22. Ohno K, Tachikawa K, Manz A. Microfluidics: applications for analytical purposes in chemistry and biochemistry. Electrophoresis 2008;29: 4443-4453.
23. Buch JS, Kimball C, Rosenberger F, et al. DNA mutation detection in a polymer microfluidic network using temperature gradient gel electrophoresis. Anal Chem 2004;76:874-881. (Pubitemid 38235533)
24. Zhang HD, Zhou J, Xu ZR, et al. DNA mutation detection with chipbased temperature gradient capillary electrophoresis using a slantwise radiative heating system. Lab Chip 2007;7:1162-1170. (Pubitemid 47295967)
25. Jia ZJ, Fang Q, Fang ZL. Bonding of glass microfluidic chips at room temperatures. Anal Chem 2004;76:5597-5602. (Pubitemid 39249450)
26. Fang Q, Xu GM, Fang ZL. A high-throughput continuous sample introduction interface for microfluidic chip-based capillary electrophoresis systems. Anal Chem 2002;74:1223-1231. (Pubitemid 34233309)
27. Gayet J, Zhou XP, Duval A, et al. Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 2001;20:5025-5032. (Pubitemid 32769792)
28. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumor. Science 1992;256:102-105.
29. Nollau P, Moser C, Weinland G, et al. Detection of K-ras mutations in stools of patients with colorectal cancer by mutation-enriched PCR. lnt J Cancer 1996;66:332-336. (Pubitemid 26163607)
30. Lev Z, Kislitsin D, Rennert G, et al. Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer. J Cell Biochem Suppl 2000;34:35-39. (Pubitemid 30176731)
31. Li Q, Liu Z, Monroe H, et al. Integrated platform for detection of DNA sequence variants using capillary array electrophoresis. Electrophoresis 2002;23:1499-1511. (Pubitemid 34649580)
32. Tada M, Omata M, Kawai S, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Journal Title: Cancer Res 1993;53:2472-2474. (Pubitemid 23168007)
33. Kahn SM, Jiang W, Culbertson TA, et al. Rapid and sensitive nonradioactive detection of mutant K-ras genes via enriched PCR amplification. Oncogene 1991;6:1079-1083. (Pubitemid 21924190)
34. Kwok S, Kellogg DE, McKinney N, et al. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res 1990; 18:999-1005.
35. Ito Y, Kobayashi S, Taniguchi T, et al. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples. Int J Oncol 2002;20:1263-1268.
36. Mixich F, Ioana M, Voinea F, et al. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer. J Gastrointestin Liver Dis 2007;16:5-10. (Pubitemid 46548583)
37. Marchetti A, Gasparini G. K-ras mutations and cetuximab in colorectal cancer. N Engl J Med 2009;360:833-834.
38. Yamashita N, Minamoto T, Ochiai A, et al. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 1995;108: 434-440.
39. Otori K, Oda Y, Sugiyama K, et al. High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut 1997;40:660-663. (Pubitemid 27278336)
40. Klaassen CH, Jeunink MA, Prinsen CF, et al. Quantification of human DNA in feces as a diagnostic test for the presence of colorectal cancer. Clin Chem 2003;49:1185-1187. (Pubitemid 36751108)
41. Haug U, Wente MN, Seiler CM, et al. Stool testing for the early detection of pancreatic cancer: rationale and current evidence. Expert Rev Mol Diagn 2008;8:753-759.
42. Petersen NJ, Nikolajsen RP, Mogensen KB, et al. Effect of Joule heating on efficiency and performance for microchip-based and capillary-based electrophoretic separation systems: a closer look. Electrophoresis 2004;25:253-269. (Pubitemid 38219789)
43. Evenhuis CJ, Haddad PR. Joule heating effects and the experimental determination of temperature during CE. Electrophoresis 2009;30: 897-909.
44. Benson SC, Mathies RA, Glazer AN. Heterodimeric DNA-binding dyes designed for energy transfer: stability and applications of the DNA complexes. Nucleic Acids Res 1993;21:5720-5726. (Pubitemid 24003101)
45. Benson SC, Mathies RA, Glazer AN. Heterodimeric DNA-binding dyes designed for energy transfer: stability and applications of the DNA complexes. Nucleic Acids Res 1993;21:5727-5735. (Pubitemid 24003102)